For the quarter ending 2026-03-31, AMWL had -$3,121K decrease in cash & cash equivalents over the period. -$988K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -10,301 | -25,169 | -31,911 | -37,887 |
| Goodwill impairment | - | 0 | - | - |
| Investment impairment | - | 1,000 | - | - |
| Impairment on right of use asset | 3,424 | - | - | - |
| Depreciation and amortization expense | 7,593 | 8,493 | 9,442 | 16,025 |
| Provisions for credit losses | 2,167 | 2,593 | -228 | 379 |
| Amortization of deferred contract acquisition costs | 647 | 661 | 665 | 1,297 |
| Amortization of deferred contract fulfillment costs | 65 | 275 | 275 | 470 |
| Accretion of discounts on debt securities | - | 0 | - | - |
| Inventory provisions | 0 | 125 | 125 | 250 |
| Interest on debt securities | - | 0 | - | - |
| Net gain on divestiture | 7,027 | -79 | -2,000 | 10,713 |
| Stock-based compensation expense | 2,304 | 4,578 | 4,083 | 13,349 |
| Loss on equity method investment | 0 | -196 | 0 | -1,500 |
| Deferred income taxes | -16 | -1,081 | -19 | -10 |
| Accounts receivable | 9,599 | -3,219 | 1,766 | -10,767 |
| Inventories | -39 | -511 | 14 | -674 |
| Deferred contract acquisition costs | 389 | 280 | 462 | 1,058 |
| Prepaid expenses and other current assets | 356 | -190 | -1,793 | 1,112 |
| Other assets | -99 | -397 | -162 | -220 |
| Accounts payable | -261 | -4,314 | 2,246 | -1,350 |
| Accrued expenses and other current liabilities | 3,367 | -329 | 5,926 | -9,239 |
| Deferred revenue | 7,261 | -8,499 | -11,083 | -13,394 |
| Net cash used in operating activities | -983 | -17,355 | -18,766 | -29,832 |
| Purchases of property and equipment | 5 | 12 | 0 | 9 |
| Capitalized software development costs | 2,781 | 0 | 0 | 0 |
| Investment in less than majority owned joint venture | - | 196 | 0 | 0 |
| Purchases of investments | 0 | 0 | 0 | 1,000 |
| Proceeds from sales and maturities of investments | - | 0 | - | - |
| Proceeds from divestiture, net of cash divested | 0 | -2,079 | 0 | 20,400 |
| Net cash provided by (used in) investing activities | -2,786 | -2,287 | 0 | 19,391 |
| Proceeds from exercise of common stock options | - | 0 | - | - |
| Proceeds from employee stock purchase plan | 303 | 0 | 300 | 544 |
| Payments for the purchase of treasury stock | 0 | 1 | 1 | 2 |
| Net cash provided by financing activities | 303 | -1 | 299 | 542 |
| Effect of exchange rates changes on cash, cash equivalents, and restricted cash | 345 | 1,083 | 283 | 655 |
| Net decrease in cash, cash equivalents, and restricted cash | -3,121 | -18,560 | -18,184 | -9,244 |
| Cash, cash equivalents, and restricted cash at beginning of period | 183,123 | 201,683 | 229,111 | - |
| Cash, cash equivalents, and restricted cash at end of period | 180,002 | 183,123 | 201,683 | - |
American Well Corp (AMWL)
American Well Corp (AMWL)